S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +0.31%
Nvidia 221.97 +2.25%
Microsoft 532.95 −0.11%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7121 +0.17%
CLOSED · 20:20 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today78 insider buys this week · $240.8MCIRO short report next: Oct 31The week ahead
LO
INSIDER · RGEN · REPLIGEN CORP · CHIEF EXECUTIVE OFFICER

Loeillot Olivier

Every open-market transaction filed under this name, Aug 20 to Oct 5.

Filings
7
0 buys · 7 sells
Bought
—
open market, at cost
Sold
$6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 5RGENREPLIGEN CORPChief Executive OfficerSell4,202$190.00$798K—
Oct 5RGENREPLIGEN CORPChief Executive OfficerSell1,333$178.75$238K—
Sep 24RGENREPLIGEN CORPChief Executive OfficerSell4,542$190.00$863K—
Sep 24RGENREPLIGEN CORPChief Executive OfficerSell8,404$190.00$1.6M—
Sep 21RGENREPLIGEN CORPChief Executive OfficerSell5,426$180.00$977K—
Sep 4RGENREPLIGEN CORPChief Executive OfficerSell3,035$165.90$504K—
Aug 20RGENREPLIGEN CORPChief Executive OfficerSell5,426$180.00$977K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.